Omega-3 fatty acids: Research

Do omega-3s lower blood fats?

Long-chain omega-3s lower triglycerides, a type of blood fat distinct from cholesterol. A Cochrane review summarized by NIH found an average reduction of about 15% across varied trials. That result does not by itself establish fewer heart attacks, and prescription omega-3 treatment should be distinguished from ordinary supplement use. 1

Why do cardiovascular trials give different answers?

In VITAL, 25,871 older adults without previous heart attacks or strokes received a daily product containing 460 mg EPA and 380 mg DHA or placebo for a median 5.3 years. The combined major cardiovascular endpoint did not improve significantly, although some coronary outcomes, including myocardial infarction, did. In REDUCE-IT, 4 g daily of prescription icosapent ethyl reduced cardiovascular events in selected statin-treated patients with elevated triglycerides. These are different products and clinical populations, not interchangeable tests of any fish-oil capsule. 1

How much does blood pressure change?

A 2022 meta-analysis of 71 randomized trials involving 4,973 adults estimated the largest average reductions around 2–3 g daily of EPA plus DHA: roughly 2.6 mmHg systolic and 1.6–1.8 mmHg diastolic. Larger responses appeared in some higher-risk groups. These are modest average changes and studied doses, not a reason to start high-dose supplementation without considering safety. 2

Blood pressureSupported

Modest average blood-pressure reductions in adult trials. 2

Does DHA support memory?

The hypothesis comes partly from DHA’s role in brain-cell membranes and observational links between fish intake and cognitive health. Trials in cognitively healthy older adults and people with Alzheimer’s disease have generally not shown cognitive benefit. Some smaller studies in mild cognitive impairment suggest improvements in particular memory or attention measures, leaving a useful question for further trials rather than a general memory claim. 1

MemoryMixed

Preliminary benefits in mild impairment; generally null trials in healthy older adults and Alzheimer’s disease. 1

What has been found during pregnancy?

Trials and systematic reviews support a reduction in preterm and early preterm birth with long-chain omega-3 intake during pregnancy. Effects on children’s cognition and vision are less consistent. A benefit for birth timing should therefore be kept separate from claims that supplements make a child more intelligent. 1

Can an anti-inflammatory mechanism help joints?

Studies in rheumatoid arthritis suggest omega-3s may help as an addition to medication, including reduced need for nonsteroidal anti-inflammatory drugs in some trials. Results for pain, swelling and stiffness differ. This is evidence about a specific inflammatory disease and adjunctive use, not proof that supplements broadly strengthen immunity or resolve every inflammatory complaint. 1